ChartMill assigns a Buy % Consensus number of 51% to NXGN. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-09-08 | Truist Securities | Maintains | Hold -> Hold |
| 2023-09-07 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2023-08-28 | Cantor Fitzgerald | Initiate | Overweight |
| 2023-07-25 | Guggenheim | Reiterate | Buy -> Buy |
| 2023-07-25 | RBC Capital | Reiterate | Sector Perform -> Sector Perform |
| 2023-07-25 | Stephens & Co. | Reiterate | Overweight -> Overweight |
| 2023-06-12 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2023-05-23 | Guggenheim | Maintains | Buy -> Buy |
| 2023-05-22 | Truist Securities | Maintains | Hold -> Hold |
| 2023-05-18 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2023-05-17 | Stephens & Co. | Reiterate | Overweight -> Overweight |
| 2023-04-12 | Stephens & Co. | Initiate | Overweight |
| 2022-10-26 | SVB Leerink | Maintains | Outperform |
| 2022-09-07 | Truist Securities | Initiate | Hold |
| 2022-05-06 | Guggenheim | Upgrade | Neutral -> Buy |
| 2022-05-04 | SVB Leerink | Maintains | Outperform |
| 2022-04-14 | Guggenheim | Initiate | Neutral |
| 2022-01-06 | SVB Leerink | Upgrade | Market Perform -> Outperform |
| 2021-07-30 | RBC Capital | Maintains | Sector Perform |
13 analysts have analysed NXGN and the average price target is 24.41 USD. This implies a price increase of 1.97% is expected in the next year compared to the current price of 23.94.
The consensus rating for NEXTGEN HEALTHCARE INC (NXGN) is 50.7692 / 100 . This indicates that analysts generally have a neutral outlook on the stock.